Sigma-Aldrich货号S6322-1VL佐剂系统(目录价¥2610.18元/支)13611631389上海睿安生物
应用Adjuvanticity Assay: EIA titer for test mice is at least 2X greater that that of control mice.
化/生理作用:Sigma佐剂系统适用于小鼠中。它是一种稳定的水包油乳液,可作为弗氏经典油包水乳液的一种替代品。该佐剂衍生自细菌和分枝杆菌细胞壁中可为免疫系统提供有效刺激的成分。
外形:在每小瓶中的2%油(角鲨烯)-Tween® 80-水中含有0.5 mg来自明尼苏达沙门氏菌的单磷酰脂质A(脱毒内毒素)以及0.5 mg合成海藻糖二十二烷酸酯。
法律信息:Sigma Adjuvant System is a registered trademark of Sigma-Aldrich Co. LLC TWEEN is a registered trademark of Croda International PLC
免责声明:除非在我们的产品目录或产品随附的其他公司文档中另有说明,我们的产品仅供研究使用并不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途、任何类型的食用或应用于人或动物。
同行评审论文(Sigma-Aldrich货号S6322-1VL佐剂系统:部分文献)
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro.
Gabriel Ozorowski et al.
Journal of virology, 92(13) (2018-04-20)
Native-like, soluble, recombinant SOSIP trimers of various designs and based on several env genes of human_immunodeficiency virus type 1 (HIV-1) are being tested as immunogens in different animal models. These experiments almost always involve coformulating the trimers with an
Development of monoclonal antibodies specific for Ricinus agglutinins
Brandon DL and Hernlem BJ
Food and agricultural immunology, 20(1), 11-22 (2009)
Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium-tuberculosis multivalent acellular vaccine.
Avi-Hai Hovav et al.
Infection and immunity, 73(1), 250-257 (2004-12-25)
In this study, we examined the immunogenicity and protective efficacy of six immunodominant Mycobacterium-tuberculosis recombinant antigens (85B, 38kDa, ESAT-6, CFP21, Mtb8.4, and 16kDa) in a multivalent vaccine preparation (6Ag). Gamma interferon (IFN-gamma) and monophosphoryl lipid A-trehalose dicorynomycolate (Ribi) adjuvant
Active immunization of hamsters against Clostridium difficile infection using surface-layer protein.
Déirdre B Ní Eidhin et al.
FEMS immunology and medical microbiology, 52(2), 207-218 (2007-12-21)
Clostridium difficile is the leading cause of infectious antibiotic-associated diarrhoea, particularly among the elderly. Its surface-layer protein (SLP) was tested as a vaccine component in a series of immunization and challenge experiments with Golden Syrian hamsters, combined with different systemic
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge.
Win-Yan Chan et al.
Infection and immunity, 87(3) (2018-12-12)
Current vaccination against Streptococcus pneumoniae uses vaccines based on capsular polysaccharides from selected serotypes and has led to nonvaccine serotype replacement disease. We have investigated an alternative serotype-independent approach, using multiple-antigen vaccines (MAV) prepared from S. pneumoniae TIGR4 lysates enriched





同行评审论文(Sigma-Aldrich货号S6322-1VL佐剂系统:部分文献)
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro.
Gabriel Ozorowski et al.
Journal of virology, 92(13) (2018-04-20)
Native-like, soluble, recombinant SOSIP trimers of various designs and based on several env genes of human_immunodeficiency virus type 1 (HIV-1) are being tested as immunogens in different animal models. These experiments almost always involve coformulating the trimers with an
Development of monoclonal antibodies specific for Ricinus agglutinins
Brandon DL and Hernlem BJ
Food and agricultural immunology, 20(1), 11-22 (2009)
Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium-tuberculosis multivalent acellular vaccine.
Avi-Hai Hovav et al.
Infection and immunity, 73(1), 250-257 (2004-12-25)
In this study, we examined the immunogenicity and protective efficacy of six immunodominant Mycobacterium-tuberculosis recombinant antigens (85B, 38kDa, ESAT-6, CFP21, Mtb8.4, and 16kDa) in a multivalent vaccine preparation (6Ag). Gamma interferon (IFN-gamma) and monophosphoryl lipid A-trehalose dicorynomycolate (Ribi) adjuvant
Active immunization of hamsters against Clostridium difficile infection using surface-layer protein.
Déirdre B Ní Eidhin et al.
FEMS immunology and medical microbiology, 52(2), 207-218 (2007-12-21)
Clostridium difficile is the leading cause of infectious antibiotic-associated diarrhoea, particularly among the elderly. Its surface-layer protein (SLP) was tested as a vaccine component in a series of immunization and challenge experiments with Golden Syrian hamsters, combined with different systemic
A Novel, Multiple-Antigen Pneumococcal Vaccine Protects against Lethal Streptococcus pneumoniae Challenge.
Win-Yan Chan et al.
Infection and immunity, 87(3) (2018-12-12)
Current vaccination against Streptococcus pneumoniae uses vaccines based on capsular polysaccharides from selected serotypes and has led to nonvaccine serotype replacement disease. We have investigated an alternative serotype-independent approach, using multiple-antigen vaccines (MAV) prepared from S. pneumoniae TIGR4 lysates enriched